The appropriate management of acute gout begins with confirming the diagnosis. When the diagnosis is uncertain consider other possible causes of joint inflammation, particularly sepsis. Anti-inflammatory therapy promptly relieves the pain of acute gout. The rapidity with which anti-inflammatory medication is commenced following the start of an attack is of greater importance than the specific drug chosen or the route of administration. Changes to therapy that aggravate the acute attack, such as altering hypouricaemic medication, should be avoided.
Introduction
Acute gout presents as an acutely inflamed joint. Other conditions have the same presentation so confirming the diagnosis is a sound platform for immediate management and good long-term advice. The diagnosis must be certain if there is a decision to use life-long hypouricaemic therapy. Aspirating the joint is ideal management 1 , but is not always possible.
The ability to aspirate the involved joint influences the choice of therapy. If infection cannot be adequately excluded then corticosteroid therapy (intra-articular or oral) is best avoided.
What causes gouty arthritis?
Sodium urate crystals sometimes form in patients with hyperuricaemia. Gout develops if there is an inflammatory reaction to these crystals.
Hyperuricaemia
In body fluids, sodium urate reaches saturation at a uric acid 
Crystal formation and the infl ammatory response
The formation of urate crystals only occurs in about 20% of people with uric acid concentrations above the saturation level, however the likelihood increases as the concentration increases. (Fig.1) The management of acute gout relies on an understanding of what is safe and appropriate when the diagnosis is likely (but may not have been proven). Therapy needs to be modified in light of other health problems, particularly contraindications to non-steroidal anti-inflammatory drugs (NSAIDs). The acute attack is also an opportunity to assess and manage associated disorders such as obesity, excessive alcohol consumption, hypertension, hyperlipidaemia and renal insufficiency.
Management
Controlling these problems may prove to be of greater longterm benefit to the patient than controlling their hyperuricaemia.
There is a strong suggestion that how soon therapy is commenced after the onset of symptoms in acute gout is more important than which treatment is chosen. A few hours can make a substantial difference.
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NSAIDs including COX-2 inhibitors

Colchicine
Although this drug has been used to treat acute gout since the sixth century and is of proven efficacy, it should rarely be prescribed as primary treatment because of its toxicity.
In the only controlled trial of colchicine in acute gout 3 , twothirds of the patients treated with colchicine had improved after 48 hours, but all had developed diarrhoea after a median of 24 hours.
Low-dose colchicine (0.5 mg twice daily) however is well tolerated and effective at preventing recurrences 4 particularly after once-off treatments such as intra-articular corticosteroid.
NSAIDs including COX-2 inhibitors can also be used to prevent recurrence.
Avoid changing hypouricaemic therapy
During the treatment of acute gout any sudden change Table 11 .1 ('Deciding whether to treat an acute exacerbation at home or in hospital') could be made more relevant to the Australian setting. It is most important for practitioners to take away the message that it is the rate of change of arterial oxygen tension that is the key issue in deciding whether someone is to be admitted, rather than the absolute value. Additionally, the absolute value given in this table is low by Australian standards.
It would also be preferable to put in oxygen saturations because pulse oximetry will become more of a standard as the equipment becomes more widely available.
n the chapter on smoking provides a broad-brush approach, but does not engage all of the specifics that can be provided in this process. It would be useful to reference Australian guidelines such as those contained in the Therapeutic Guidelines: Respiratory.
Overall the book is going to be a useful reference for people to brush up on issues with regard to COPD management and to provide accurate information to the patient.
